Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors

Table 1 Patient characteristics and procedure specifications

Age	Sex	Diagnosis	No. of RF applications/session	No of sessions	Dead/alive
5 Watts
82	F	Mucinous cyst	3	1	Alive
73	F	Mucinous cyst	5	1	Alive
46	F	Microcystic adenoma	5	1	Alive
15 Watts
40	F	Mucinous cyst	3	1	Alive
27	F	Mucinous cyst	2	1	Alive
20 Watts
57	F	NET	6	1	Alive
82	F	NET	4	2	Alive
25 Watts
78	M	IPMN	7	1	Alive

IPMN: Intraductal papillary mucinous neoplasm; NET: Neuroendocrine tumors; RF: Radiofrequency; F: Female; M: Male.

Table 2 Outcome after endoscopic ultrasound radiofrequency ablation of pancreatic cystic neoplasm and neuroendocrine tumors

No.	Diagnosis	Pre ablationsize (mm)	Post ablation size (mm)	Adverse events
1	Mucinous cyst	30	10	No
2	Mucinous cyst	40	Cyst not seen	No
3	Microcystic adenoma	20	8	No
4	Mucinous cyst	70	45	Mild pain
5	Mucinous cyst	24	Cyst not seen	Mild pain
6	IPMN	35	17	No
7	NET	15	Change in vascularity	No
8	NET	40	Central area of necrosis 15 mm	No

IPMN: Intraductal papillary mucinous neoplasm; NET: Neuroendocrine tumors.